Non-invasive health indicator monitoring system and using method thereof
US-2015201837-A1 · Jul 23, 2015 · US
US11042044B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11042044-B2 |
| Application number | US-201715789440-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 20, 2017 |
| Priority date | Mar 17, 2017 |
| Publication date | Jun 22, 2021 |
| Grant date | Jun 22, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A contact lens containing a photonic crystal which is configured to change color depending on a concentration of an analyte in the tears of a subject. The change in color is reversible. The contact lens may be useful for monitoring the concentration of glucose in tears of a diabetic subject or a prediabetic subject.
Opening claim text (preview).
The invention claimed is: 1. A contact lens, comprising: a photonic crystal comprising: a plurality of metal nanoparticle stacks comprising metal nanoparticles, wherein the plurality of metal nanoparticle stacks are spaced such that each metal nanoparticle stack of the plurality of metal nanoparticle stacks is substantially parallel to one another, and wherein a distance between adjacent metal nanoparticle stacks increases or decreases in response to a concentration of an analyte thereby producing a shift in a photonic band gap and a color change in the photonic crystal; a sensor for measuring the shift in the photonic band gap, and a hydrogel matrix comprising polyhydroxyethylmethacrylate; wherein the plurality of metal nanoparticle stacks is arranged within the hydrogel matrix. 2. The contact lens of claim 1 , wherein the metal nanoparticles comprise at least one metal selected from a group consisting of silver, gold, titanium, platinum, iron, cobalt, chromium, molybdenum, vanadium, tin, nickel, and niobium. 3. The contact lens of claim 1 , wherein each metal nanoparticle stack of the plurality of metal nanoparticle stacks comprises 20-200 metal nanoparticles. 4. The contact lens of claim 1 , wherein the photonic crystal comprises up to 100 metal nanoparticle stacks. 5. The contact lens of claim 4 , wherein the photonic crystal comprises 3-6 metal nanoparticle stacks. 6. The contact lens of claim 1 , wherein the distance between adjacent metal nanoparticle stacks is in a range of 140-250 nm. 7. The contact lens of claim 1 , wherein the plurality of metal nanoparticle stacks has a tilt angle in a range of 1-30° measured from a plane of a metal nanoparticle stack to a surface plane of the photonic crystal. 8. The contact lens of claim 1 , wherein the metal nanoparticles are spherical. 9. The contact lens of claim 1 , wherein the metal nanoparticles have an average diameter in a range of 2-20 nm. 10. The contact lens of claim 9 , wherein the average diameter of the metal nanoparticles varies between each metal nanoparticle stack. 11. The contact lens of claim 1 , wherein the metal nanoparticles are randomly dispersed within each metal nanoparticle stack. 12. The contact lens of claim 1 , wherein each metal nanoparticle stack of the plurality of metal nanoparticle stacks comprises metal nanoparticles of monodisperse diameter. 13. The contact lens of claim 1 , wherein the shift in the photonic band gap is reversible. 14. The contact lens of claim 1 , wherein the color change is reversible. 15. The contact lens of claim 1 , wherein the analyte is glucose. 16. A method for detecting a glucose concentration of a subject, the method comprising: wearing the contact lens of claim 1 , thereby contacting the contact lens to tears produced by the subject; and detecting the shift in the photonic band gap. 17. The method of claim 16 , wherein the photonic crystal changes color in response to the glucose concentration in the tears. 18. The method of claim 16 , wherein the subject has diabetes. 19. The contact lens of claim 1 , wherein the metal nanoparticle stacks are spaced such that each metal nanoparticle stack of the plurality of metal nanoparticle stacks is aligned to one another at no more than 5° from parallel. 20. The contact lens of claim 1 , wherein the metal nanoparticle stacks are spaced such that each metal nanoparticle stack of the plurality of metal nanoparticle stacks is aligned parallel to one another.
Producing lenses combined with electronics, e.g. chips · CPC title
Production of contact lenses · CPC title
Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title
Eye · CPC title
Contact lenses having special fitting or structural features achieved by special materials or material structures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.